Only a 1/3 of Patients take all their medicine...1/3 take some...1/3 none at all

April 19, 2006

Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever.

Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever. As a result, pharmaceutical companies bear a drastic fall in revenues. AXA Assistance, experts in delivering/ leading providers of patient communication programmes, can share more than 8 years' experience in tailoring and managing successful compliance programmes.

As part of the AXA Global Group and one of the world?s top 20 companies, our service centres operate 24/7/365 out of over 30 sites around the world, offering tailored solutions to the pharmaceutical industry. We have supported many brands and, with an average increase in compliance of 30%, demonstrated a profitable return on investment.

Our core services include:

  • Compliance Programmes


  • Product Support Programmes


  • Medical Information Departments


  • Issues Management Programmes


  • Representative Sales Support


We believe that we have broken new ground by being the first company that truly meets all objectives of improving patient compliance. The principle aim is for patients and healthcare professionals to reap the benefits in turn deriving the maximum benefit for your brand. AXA Assistance ensure that the following is delivered as a minimum on all programmes implemented:

  • Increased number of days on therapy demonstrating profitable return on Investment
  • Confidence that the programme is regulatory compliant
  • Consistent results associated with the medication evident due to enhanced compliance levels compared with other therapies

For further details contact:

Sunita Apte, Pharmaceutical Business Manger
Tel: +44 (0) 870 2406541
sunita.apte@axa-assistance.co.uk

Or visit www.axa-assistance.co.uk

Related Content:

News